Concomitant product(s): product id: 8711, serial# (b)(4), implanted: (b)(6) 2007, product type: catheter.Product id: 8711, lot# j10874r19, implanted: (b)(6) 2001, product type: catheter.Product id: 8596, serial# (b)(4), implanted: (b)(6) 2007, product type: catheter.Product id: 8596sc, serial# (b)(4), implanted: (b)(6) 2013, product type: catheter.Other relevant device(s) are: product id: 8711, serial/lot #: (b)(4), ubd: 04-oct-2008, udi#:(b)(4); product id: 8711, serial/lot #: (b)(4), ubd: 31-jul-2003, udi#: (b)(4); product id: 8596, serial/lot #: (b)(4), ubd: 29-nov-2008, udi#: (b)(4); product id: 8596sc, serial/lot #: (b)(4), ubd: 01-jul-2015, udi#: (b)(4).If information is provided in the future, a supplemental report will be issued.
|
Information was received from a healthcare professional (hcp) regarding a patient receiving bupivacaine (5 mg/ml at an unknown dose) and dilaudid (1 mg/ml at an unknown dose) via an implanted pump.The indication for pump use was failed back surgery syndrome, non-malignant pain, and spinal pain.On (b)(6) 2018 it was reported that it was confirmed that the catheter was occluded.A dye study and imaging (mri, ct scan) had been done.They could not aspirate from the cap (catheter access port) at the dye study.There was also a volume discrepancy where the reporter almost got back a full reservoir of drug.They were not sure if the catheter was occluded due to a granuloma (inflammatory mass) or if the catheter was blocked for another reason.An mri was performed, but the reporter had limited details.The patient had been ¿getting worse and not getting good therapy¿ beginning earlier this year.The reporter had purposefully programmed the pump to stopped pump mode and the stopped pump alarm was sounding at the time of the report.Silencing the alarm and other options were reviewed.No further complications have been reported as a result of this event.
|